Quantbot Technologies LP Kymera Therapeutics, Inc. Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$20.91 - $34.27 $137,775 - $225,805	6,589 New	6,589 $143,000
Q2 2022 Aug 09, 2022	SELL	$14.13 - $42.55 $21,195 - $63,824	-1,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $7,059 - $12,936	200 Added 15.38%	1,500 $63,000
Q4 2021 Feb 11, 2022	BUY	$49.91 - $65.56 $14,972 - $19,668	300 Added 30.0%	1,300 $82,000
Q3 2021 Nov 09, 2021	BUY	$47.8 - $66.66 $47,800 - $66,660	1,000 New	1,000 $58,000

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.28B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.